Blog
RSS FeedPosted by Michael Wonder on 27 Jul 2019
Stories of patient involvement impact in health technology assessments: a discussion paper
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
Posted by Michael Wonder on 26 Jul 2019
Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund
26 July 2019 - Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ...
Posted by Michael Wonder on 22 Jul 2019
NICE numbers at 20
19 July 2019 - Leela Barham takes a look at NICE’s stats on technology appraisals to see how the agency ...
Posted by Michael Wonder on 22 Jul 2019
Government to invest £16 million in 'life-saving' medical advances
22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...
Posted by Michael Wonder on 22 Jul 2019
NICE announces details of health technology evaluation methods review
22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...
Posted by Michael Wonder on 15 Jul 2019
NICE recommends Skyrizi, Forxiga
15 July 2019 - NICE has recommended two new drugs on the NHS, AbbVie’s Skyrizi (risankizumab) and AstraZeneca’s Forxiga (dapagliflozin) ...
Posted by Michael Wonder on 12 Jul 2019
NICE recommends innovative treatment for type 1 diabetes
12 July 2019 - It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin. ...
Posted by Michael Wonder on 08 Jul 2019
Cystic fibrosis scandal: Drugs boss tells boy, 9, he wants NHS deal to save lives
8 July 2019 - The millionaire boss of a US drugs firm has penned a personal letter to a boy with ...
Posted by Michael Wonder on 08 Jul 2019
NHS England scraps 7 more drugs on prescription
8 July 2019 - NHS England has issued a new guidance scrapping seven medicines from its prescriptions list, estimating to save ...
Posted by Michael Wonder on 08 Jul 2019
AstraZeneca boss calls for NHS drug approval shake-up
5 July 2019 - AstraZeneca has called for a wholesale review of the way new drugs are paid for in ...
Posted by Michael Wonder on 07 Jul 2019
AZ appeals against NICE rejection of Tagrisso in untreated lung cancer
5 July 2019 - AstraZeneca is appealing against NICE’s decision not to recommend funding for its lung cancer drug Tagrisso ...
Posted by Michael Wonder on 05 Jul 2019
Life-extending lung cancer treatment recommended for use on the NHS
5 July 2019 - Dacomitinib has been recommended as a first-line treatment option for people with a type of non-small-cell lung ...
Posted by Michael Wonder on 02 Jul 2019
Immediately after EU nod, England’s NHS funds Sanofi skin cancer drug
2 July 2019 - Patients in England will be among those who are first to benefit from Sanofi and Regeneron’s ...
Posted by Michael Wonder on 27 Jun 2019
Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements
27 June 2019 - No new government funds committed to no-deal medicines plans. ...
Posted by Michael Wonder on 26 Jun 2019
NICE to make changes to health technology evaluation
26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in ...